Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Céleste, Lebbe"'
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 10, Pp n/a-n/a (2023)
Abstract Background Although the PI3K/AKT/mTOR pathway is one of the most altered pathways in human tumours, therapies targeting this pathway have shown numerous adverse effects due to positive feedback paradoxically activating upstream signaling nod
Externí odkaz:
https://doaj.org/article/d7fdc434ab2047cf992f35c8547a459d
Autor:
Pierre Kubicek, Axel Le Cesne, Cyril Lervat, Maud Toulmonde, Christine Chevreau, Florence Duffaud, Louis-Romée Le Nail, Magali Morelle, Nathalie Gaspar, Cécile Vérité, Marie-Pierre Castex, Nicolas Penel, Esma Saada, Sylvain Causeret, François Bertucci, Christophe Perrin, Emmanuelle Bompas, Daniel Orbach, Valérie Laurence, Sophie Piperno-Neumann, Philippe Anract, Maria Rios, Jean-Claude Gentet, Éric Mascard, Stéphanie Pannier, Pascale Blouin, Sébastien Carrère, Loïc Chaigneau, Pauline Soibinet-Oudot, Nadège Corradini, Pascaline Boudou-Rouquette, Jean-Christophe Ruzic, Valérie Lebrun-Ly, Pascale Dubray-Longeras, Sharmini Varatharajah, Céleste Lebbe, Mickaël Ropars, Jean-Emmanuel Kurtz, Cécile Guillemet, Jean-Pierre Lotz, Juliane Berchoud, Grégory Cherrier, Françoise Ducimetière, Claire Chemin, Antoine Italiano, Charles Honoré, Emmanuel Desandes, Jean-Yves Blay, François Gouin, Perrine Marec-Bérard
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background The initial management of patients with sarcoma is a critical issue. We used the nationwide French National Cancer Institute-funded prospective sarcoma database NETSARC to report the management and oncologic outcomes in adolescent
Externí odkaz:
https://doaj.org/article/818492c9520b4b0e97c3002982a8e77a
Autor:
Marguerite Kandel, Aurélie Bardet, Stéphane Dalle, Clara Allayous, Laurent Mortier, Bernard Guillot, Caroline Dutriaux, Marie-Thérèse Leccia, Sophie Dalac, Henri Montaudie, Philippe Saiag, Delphine Legoupil, Florence Brunet-Possenti, Jean-Philippe Arnault, Julie De Quatrebarbes, Marie Beylot-Barry, Eve Maubec, Thierry Lesimple, François Aubin, Jean-Jacques Grob, Florence Granel-Brocard, Pierre-Emmanuel Stoebner, Alain Dupuy, Brigitte Dreno, Stefan Michiels, Céleste Lebbe, Isabelle Borget
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9255-9270 (2022)
Nine drugs have been marketed for 10 years for the treatment of advanced melanoma (AM). With half of patients reaching a second line, the optimal sequence of treatments remains unclear. To inform policy-makers about their efficiency, we performed a c
Externí odkaz:
https://doaj.org/article/029219c40f474f67aac932d94f25d323
Publikováno v:
Bulletin de l'Académie Nationale de Médecine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a60200079e9280b7c16ccb1395277495
https://doi.org/10.1016/j.banm.2023.03.019
https://doi.org/10.1016/j.banm.2023.03.019
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Figure S2. (A) Change in the tumor burden from baseline over time according to RECIST for all the included patients. The tumor burden was measured as the sum of the longest diameters of target lesions. Each line represents a patient. (B) Kaplan-Meier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::272e3c9431d2fe17ad4e23f5c0092460
https://doi.org/10.1158/1078-0432.22480554
https://doi.org/10.1158/1078-0432.22480554
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Purpose:In BRAFV600MUT metastatic melanoma, cyclin D–CDK4/6–INK4–Rb pathway alterations are involved in resistance to MAPK inhibitors, suggesting a clinical benefit of cyclin-dependent kinase 4 (CDK4) inhibitors. In this phase I–II study, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3af0eef26415c8819e4c5b5543de08
https://doi.org/10.1158/1078-0432.c.6530460
https://doi.org/10.1158/1078-0432.c.6530460
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0cb79529fe16cf7b7f5ecfa443c579
https://doi.org/10.1158/1078-0432.22480545
https://doi.org/10.1158/1078-0432.22480545
Autor:
Céleste Lebbe, Samia Mourah, Maxime Battistella, Keyvan Rezai, Samuel Huguet, Annick Tibi, Didier Bouton, Paul Vilquin, Zineb Ghrieb, Fanélie Jouenne, Aurélie Sadoux, Coralie Reger de Moura, Caroline Dutriaux, Mona Amini-Adle, Julie Delyon, Barouyr Baroudjian, Marc Pracht, Laetitia Da Meda, Thierry Lesimple, Matthieu Resche-Rigon, Baptiste Louveau
Tables S1, S2, S3, S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0565bed1a58abc520acba9f808af10fa
https://doi.org/10.1158/1078-0432.22480542
https://doi.org/10.1158/1078-0432.22480542
Autor:
Julie, Delyon, Lucie, Biard, Marion, Renaud, Matthieu, Resche-Rigon, Jérôme, Le Goff, Stéphane, Dalle, Valentine, Heidelberger, Laetitia, Da Meda, Laurie, Toullec, Guislaine, Carcelain, Samia, Mourah, Sophie, Caillat-Zucman, Vincent, Allain, Maxime, Battistella, Céleste, Lebbe
Publikováno v:
The Lancet Oncology. 23:491-500
Although the treatment of iatrogenic and HIV-related Kaposi sarcoma is well defined and mostly based on restoring immune function, the treatment of classic and endemic Kaposi sarcoma is less well established. Chemotherapy or interferon α is used for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f1a2b92cd8c22943f8e31a947ea343
https://doi.org/10.1016/s1470-2045(22)00097-3
https://doi.org/10.1016/s1470-2045(22)00097-3